Cosentyx snrdy 300MG dose-2PENML
Ended Awarded
- Contract number
- SPE2DB26FDR41
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $46,925
Award facts
- Contract value 100% obligated
- $46,925.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 16, 2025, for the supply of Cosentyx (secukinumab) 300mg dose in 2-pen/mL configuration, valued at $46,925.40. This firm fixed-price delivery order, with an ultimate completion date of October 17, 2025, represents a non-set-aside competitive award for pharmaceutical supplies to support federal medical procurement needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order as a child contract under its larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), an approximately $1 billion vehicle running through December 2026.
As a critical vendor in the federal medical supply chain, AmerisourceBergen Drug Corp leverages its comprehensive indefinite delivery contract with the Defense Logistics Agency to deliver specialty medications and pharmaceutical products to support military healthcare systems and other government agencies, including the Defense Health Agency and U.S. Coast Guard. This particular delivery order for Cosentyx—a biologic immunosuppressant used in the treatment of various inflammatory and autoimmune conditions—reflects the contractor's established capability to supply brand-name specialty pharmaceuticals through competitive federal procurement processes. The order demonstrates the company's role in providing critical medical commodities to support military personnel and veteran healthcare programs.
Quick answers
Who was awarded contract SPE2DB26FDR41?
SPE2DB26FDR41 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 16, 2025.
How much is contract SPE2DB26FDR41 worth?
The government has obligated $46,925 on SPE2DB26FDR41.
Is contract SPE2DB26FDR41 an order under another contract?
Yes. SPE2DB26FDR41 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB26FDR41 competed?
The extent of competition for SPE2DB26FDR41 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award